2021
DOI: 10.1128/mbio.01115-21
|View full text |Cite
|
Sign up to set email alerts
|

Engineered Type Six Secretion Systems Deliver Active Exogenous Effectors and Cre Recombinase

Abstract: Delivery of protein-based drugs, antigens, and gene-editing agents has broad applications. The type VI protein secretion system (T6SS) can target both bacteria and eukaryotic cells and deliver proteins of diverse size and function.

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
26
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1
1

Relationship

3
5

Authors

Journals

citations
Cited by 20 publications
(28 citation statements)
references
References 54 publications
(76 reference statements)
0
26
1
Order By: Relevance
“…To test how effectors are specifically recognized by cognate VgrGs in SSU, we swapped the VgrG3 tail sequence (P650 to end) with the ones from VgrG1 (K650 to end) and VgrG2 (E650 to end) to test whether these chimeric VgrG3 variants can functionally complement the deletions of the corresponding vgrGs ( Next, we tested whether VgrG-tail swapping could deliver an effector of another species. This is different from our recent report that an effector from A. dhakensis was delivered by the T6SS of V. cholerae as a hybrid fusion to the PAAR2 protein [43]. We expressed VasX, a T6SS effector in V. cholerae, and its associated chaperone VasW and immunity protein TsiV2 in SSU (Fig 2C).…”
Section: Vgrg C-terminal Divergent Tail Dictates Effector Delivery Specificitycontrasting
confidence: 80%
See 1 more Smart Citation
“…To test how effectors are specifically recognized by cognate VgrGs in SSU, we swapped the VgrG3 tail sequence (P650 to end) with the ones from VgrG1 (K650 to end) and VgrG2 (E650 to end) to test whether these chimeric VgrG3 variants can functionally complement the deletions of the corresponding vgrGs ( Next, we tested whether VgrG-tail swapping could deliver an effector of another species. This is different from our recent report that an effector from A. dhakensis was delivered by the T6SS of V. cholerae as a hybrid fusion to the PAAR2 protein [43]. We expressed VasX, a T6SS effector in V. cholerae, and its associated chaperone VasW and immunity protein TsiV2 in SSU (Fig 2C).…”
Section: Vgrg C-terminal Divergent Tail Dictates Effector Delivery Specificitycontrasting
confidence: 80%
“…dhakensis was delivered by the T6SS of V . cholerae as a hybrid fusion to the PAAR2 protein [ 43 ]. We expressed VasX, a T6SS effector in V .…”
Section: Resultsmentioning
confidence: 99%
“…For example, T3SSs from diverse pathogenic bacteria were used as translocation tools to deliver proteins into mammalian cells ( 4 , 5 ). T6SS, another widespread injectisome in pathogens, was developed as delivery vector in biotechnological applications ( 30 , 31 ). Many other protein complexes, such as Tc toxins ( 10 , 11 ), type IV pilins ( 32 , 33 ) and pore-forming proteins ( 34 , 35 ), were also used to accomplish similar assignments toward eukaryotic cells, particularly killing cancer cells ( 36 ).…”
Section: Discussionmentioning
confidence: 99%
“…Data are shown as either Log 10 c.f.u recovered on LB plates with appropriate antibiotics or as recombination efficiency, calculated as Gen R c.f.u/Carb R c.f.u. If no colonies were observed, samples were listed as the detection limit (DL), shown as if 0.5 colonies were counted 22 . Error bars show the mean ± standard deviation of three biological replicates.…”
Section: Cre Delivery Assaymentioning
confidence: 99%
“…These effectors may not only dictate functions but also directly contribute to T6SS assembly because deletion of multiple effector genes abolishes T6SS assembly in several species 9,18,20 . Similar to the spike complex proteins, VgrG and PAAR, some effectors can also serve as carriers when fused with cargo proteins 8,9,21,22 . Therefore, rather than deleting effector genes, an effective strategy has been developed in Vibrio cholerae and Aeromonas dhakensis to use catalytic mutations of effectors to detoxify the T6SS while maintaining the delivery function 9,20,22 .…”
Section: Introductionmentioning
confidence: 99%